Requires the drug Leuprolide acetate, to be labeled with a warning of the possible side effects thereof.
Sponsor: Rivera N / Multi-sponsor(s): Camara, Duprey, Finch, Linares, Maisel, McDonough, Montesano, Moya, Ortiz, Raia, Rivera J, Rodriguez, Saladino, Schimel / Co-sponsor(s): Crespo, Aubry, Cook, Arroyo, McEneny, Englebright, Rivera P, Miller M, Castro, Stevenson, Ramos, Jaffee, Roberts, Jacobs, Weprin, Robinson, Scarborough
Law Section: Education Law / Law: Add S6811-c, Ed L
Sponsor: Rivera N / Multi-sponsor(s): Camara, Duprey, Finch, Linares, Maisel, McDonough, Montesano, Moya, Ortiz, Raia, Rivera J, Rodriguez, Saladino, Schimel / Co-sponsor(s): Crespo, Aubry, Cook, Arroyo, McEneny, Englebright, Rivera P, Miller M, Castro, Stevenson, Ramos, Jaffee, Roberts, Jacobs, Weprin, Robinson, Scarborough
Law Section: Education Law / Law: Add S6811-c, Ed L
A6386-2011 Actions
- Jan 4, 2012: referred to higher education
- May 3, 2011: reference changed to higher education
- Mar 16, 2011: referred to consumer affairs and protection
A6386-2011 Text
S T A T E O F N E W Y O R K
6386 2011-2012 Regular Sessions I N ASSEMBLY March 16, 2011
Introduced by M. of A. N. RIVERA, CRESPO, AUBRY, COOK, ARROYO, McENENY, ENGLEBRIGHT, P. RIVERA, M. MILLER, CASTRO, STEVENSON, RAMOS, JAFFEE, ROBERTS -- Multi-Sponsored by -- M. of A. CAMARA, DUPREY, LINARES, MAISEL, McDONOUGH, MONTESANO, MOYA, ORTIZ, RAIA, J. RIVERA, RODRIGUEZ, TOWNS -- read once and referred to the Committee on Consumer Affairs and Protection AN ACT to amend the education law, in relation to the labeling of Leuprolide acetate THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM BLY, DO ENACT AS FOLLOWS:
Section 1. The education law is amended by adding a new section 6811-c to read as follows:
S 6811-C. LEUPROLIDE ACETATE. NO PHARMACIST SHALL DISPENSE OR SELL THE DRUG LEUPROLIDE ACETATE, ALSO KNOWN AND MARKETED AS LUPRON, LUPRON DEPOT, LUPRON DEPOT-PED, VIADUR AND ELIQARD, UNLESS THE CONTAINER CONTAINING SUCH DRUG PROVIDED TO THE CONSUMER IS LABELED WITH THE FOLLOWING WARNING:
"CAUTION: THIS DRUG COULD CAUSE ADVERSE REACTIONS INCLUDING, BUT NOT LIMITED TO, HEART ATTACKS, DIABETES, CONVULSIONS, EXCESSIVE BLEEDING AND COULD LEAD TO DEATH."
S 2. This act shall take effect on the first of January next succeed ing the date on which it shall have become a law. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD08549-01-1

*By contributing or voting you agree to the Terms of Participation and Privacy Policy and verify you are over 13.
Discuss!
blog comments powered by Disqus